Current status of haploidentical stem cell transplantation for leukemia

Current status of haploidentical stem cell transplantation for leukemia

<p>Abstract</p> <p>Haploidentical hematopoietic stem cell transplantation has made tremendous progress over the past 20 years and has become a feasible option for leukemia patients without a HLA identical sibling donor. The early complications of severe graft-versus-host disease (G...

Full description

Bibliographic Details
Main Author:	Huang Xiao-jun
Format:	Article
Language:	English
Published:	BMC 2008-12-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/1/1/27

Similar Items

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
by: Ying-Jun Chang, et al.
Published: (2021-10-01)

Haploidentical haematopoeitic stem cell transplants (Hsct) in paediatric acute leukemia
by: Sohini Chakraborty, et al.
Published: (2017-01-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Strategies in Haploidentical Stem Cell Transplantation in Adults
by: Ulaş D. Bayraktar, et al.
Published: (2013-12-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Successful haploidentical stem cell transplantation for therapy‐related acute myeloid leukemia after autologous transplantation of Hodgkin lymphoma
by: Chien‐Yu Ker, et al.
Published: (2022-08-01)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
by: Jacopo Mariotti, et al.
Published: (2020-11-01)

First Successful Haploidentical Stem Cell Transplantation in Romania
by: Tănase Alina, et al.
Published: (2016-09-01)

CELLULAR AND MOLECULAR BASIS OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE SUCCESSFUL TREATMENT OF HIGH RISK LEUKEMIAS.
by: FRANCO eLOCATELLI, et al.
Published: (2013-02-01)

P573: NOVEL PROGNOSTIC MODEL FOR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Qi Wen, et al.
Published: (2023-08-01)

Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
by: Uday Kulkarni, et al.
Published: (2023-09-01)

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
by: Simona Piemontese, et al.
Published: (2017-01-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
by: Rajesh B Sawant, et al.
Published: (2023-01-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01)

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
by: Nicole Santoro, et al.
Published: (2017-05-01)

Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
by: Xun-Hong Cao, et al.
Published: (2024-03-01)

Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia
by: Jong-Hyuk Lee, et al.
Published: (2023-01-01)

Haploidentical stem cell transplants with Post transplantation cyclophosphamide for Hematological malignancies in children
by: Neha Rastogi, et al.
Published: (2016-01-01)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
by: Ping Zhang, et al.
Published: (2019-08-01)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
by: Naoki Okada, et al.
Published: (2023-08-01)

Review of Haploidentical Hematopoietic Cell Transplantation
by: Mehreen A. Khan, et al.
Published: (2018-12-01)

The Evolution of T Cell Depleted Haploidentical Transplantation
by: Franco Aversa, et al.
Published: (2019-11-01)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
by: Takafumi Tsushima, et al.
Published: (2022-08-01)

Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
by: Pier Edoardo Rovatti, et al.
Published: (2020-02-01)

T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients
by: Pietro Sodani, et al.
Published: (2011-06-01)

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
by: Hideki Sano, et al.
Published: (2021-10-01)

Resolution of bone, cutaneous, and muscular involvement after haploidentical hematopoietic stem cell transplantation followed by post‐transplant cyclophosphamide in adult T‐cell leukemia/lymphoma
by: Futoshi Iioka, et al.
Published: (2020-08-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

Impact of Lymphocyte Subsets of Grafts on the Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation
by: Peiyao Jiang, et al.
Published: (2023-03-01)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
by: Jing-Zhi Wang, et al.
Published: (2021-10-01)

Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?
by: Juan Carlos Olivares-Gazca, et al.
Published: (2023-12-01)

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
by: Fabio Ciceri, Marco Bregni, Jacopo Peccatori
Published: (2011-01-01)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
by: Junbin Huang, et al.
Published: (2023-02-01)

Clofarabine-based conditioning for T-cell replete haploidentical hematopoietic stem cell transplant for relapsed/refractory acute leukemia using peripheral blood stem cell grafts and post-transplantation cyclophosphamide
by: Prashant Mehta, et al.
Published: (2020-01-01)

Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
by: Junjie Cao, et al.
Published: (2023-12-01)

A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia
by: Haibo Zhu, et al.
Published: (2022-08-01)

T cell depleted haploidentical transplantation: positive selection
by: Franco Aversa
Published: (2011-06-01)

Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
by: Yongzhan Zhang, et al.
Published: (2022-04-01)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Li-Ping Dou, et al.
Published: (2018-01-01)